The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model

Transplantation

Volumn 56, Issue 1, 1993, Pages 1-8

  Leventhal, Joseph R ^a   Matas, Arthur J ^a   Sun, Lin Hong ^a   Reif, Sally ^a   Bolman, R Morton ^a   Dalmasso, Agustin P ^a   Platt, Jeffrey L ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ALBUMIN; COBROTOXIN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DEPLETION; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIG; HEART TRANSPLANTATION; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; NATURAL KILLER CELL; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RAT; SPLENECTOMY; XENOGRAFT;

ANIMAL; ANTIBODIES; COMPLEMENT; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; GUANIDINES; GUINEA PIGS; HEART TRANSPLANTATION; IMMUNOGLOBULIN M; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; PLASMA EXCHANGE; RATS; RATS, INBRED LEW; SPLENECTOMY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0027220778     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199307000-00001     Document Type: Article

References (37)

1. Platt JL, Bach FH, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
2. Auchincloss H, Jr. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
3. Platt JL, Bach FH. Mechanisms of tissue injury in hyperacute xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG (eds). Xenotransplantation. New York: Springer, 1992: 69.
4. Caine RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
5. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
6. Gewürz H, Clark D, Finstad J, et al. Role of the complement system in graft rejections in experimental animals and man. Ann NY Acad Sei 1966; 129: 673.
7. Schilling A, Lend W, Pratschke E, et al. Dominant role of complement in the hyperacute xenograft rejection reaction. Surg Gynecol Obstet 1976; 142: 29.
8. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 1037.
9. Inverardi L, Sarnaja M, Marelli F, et al. Cellular early immune recognition of xenogeneic vascular endothelium. Transplant Proc 1992; 24: 459.
10. Kirk AD, Hall BL, Finn OJ, Bollinger RR. In vitro analysis of the human antiporcine T-cell repertoire. Transplant Proc 1992; 24: 602.
11. Platt JL, Fischel RJ, Matas AJ, et al. Immunopathology of hyperacute rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
12. Platt JL, Vercellotti GM, Lindman B, et al. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1363.
13. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody absorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
14. Miyagawa S, Irose H, Shikakura R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
15. Pruitt SK, Baldwin WM, Marsh HC, et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868.
16. Johnston P, Lim S, Wright L, White D. Hyperacute xenograft rejection takes place in the complete absence of antibodies but requires the presence of functional complement. Transplant Proc 1991; 23: 877.
17. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54: 26.
18. Leventhal JR, Dalmasso AP, Cromwell JC, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
19. Beukelman CJ, Aerts PC, Van Dijk H, Willers JMN. A one-step isolation procedure for phospholipase A2-free cobra venom factor by fast protein liquid chromatography. J Immunol Methods 1987; 97: 119.
20. Ballow M, Cochrane CG. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol 1969; 103: 944.
21. Vogel CW, Pluckthun A, Muller-Eberhard HJ, et al. Hemolytic assay for venom phospholipase A2. Anal Biochem 1981; 118: 262.
22. Kabat EA, Mayer MM, Experimental immunochemistry 1961 (2nd ed). Springfield, IL: Thomas: 149.
23. Platt-Mills TAE, Ishizaka K. Activation of the alternate pathway of human complement by rabbit cells. J Immunol 1974; 113: 348.
24. Leventhal JR, Figueroa J, Flores HC, et al. Measurement of natural antibody (NA) in a discordant xenograft model. Transplant Proc 1992; 24: 455.
25. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
26. Rose AG. Histopathology of cardiac xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG (eds). Xenotransplantation. Springer, 1992: 139.
27. Forbes RDC, Kuramochi T, Guttmann RD, et al. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab Invest 1975; 33: 280.
28. Rose AG, Cooper DKC, Human PA, et al. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991; 10: 223.
29. Paul LC, Van Es LA, De La Riviere GB, et al. Blood group B antigen on renal endothelium is the target for rejection in an ABO-incompatible recipient. Transplantation 1978; 26: 268.
30. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: initial immunopathologie evaluation. Transplant Proc 1987; 19: 4553.
31. Pruitt SK, Baldwin WM, Barth R, et al. The effect of B cell and natural antibody depletion on guinea pig cardiac xenograft survival in the rat. (presented at the 19th Annual Scientific Meeting of the American Society of Transplant Surgeons, Chicago, IL, 1992).
32. Demetris AJ, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allografts: a study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489.
33. Alexandre GPJ, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA (ed.) Xenograft 25. New York: Elsevier, 1989: 259.
34. Grasi CK, Avis PJ, Hali JG, et al. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells. Transplantation 1971; 11: 356.
35. Pardi R, Inverardi L, Bender J. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today 1992; 13: 224.
36. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13: 93.
37. Dauchel H, Julen N, Lemercier C, et al. Expression of complement alternative pathway proteins by endothelial cells: differential regulation by interleukin 1 and glucocorticoids. Eur J Immunol 1990; 20: 1669.